Editorial: Predictive Factors and Survival Outcome of Conversion Therapy for Unresectable Hepatocellular Carcinoma Patients Receiving Atezolizumab and Bevacizumab: Comparative Analysis of Conversion, Partial Response and Complete Response Patients. Authors' Reply. - Hatanaka T; Kakizaki S; Hiraoka A; Tada T; Kumada T (Alimentary pharmacology & therapeutics, 2024)